Profusa, Inc. PFSA
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
2/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Financials | ||||
| Revenue | — | $100,000 | — | — |
| Operating income | -$27.7M | -$4.5M | -$1.5M | -$1.3M |
| Net income | -$35.8M | -$9.2M | $1.2M | $7.2M |
| Operating cash flow | -$16.2M | -$2.1M | -$2.1M | -$581,189 |
| Free cash flow | -$16.3M | — | — | — |
| Total assets | $3.8M | $3.1M | $10.9M | $194.7M |
| Total liabilities | $30.4M | $57.1M | $5.1M | $1.8M |
| Shareholders' equity | -$26.7M | -$119.2M | -$110.0M | -$619,476 |
| Ratios | ||||
| Operating margin | — | -4500.0% | — | — |
| Net margin | — | -9230.0% | — | — |
| Return on assets | -949.0% | -300.4% | 10.7% | 3.7% |
| Return on equity | 134.4% | 7.7% | -1.1% | -1157.1% |
| Current ratio | 0.17 | 0.00 | 0.32 | 0.55 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001859807 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.